Literature DB >> 17335318

Health-related quality of life in euthymic bipolar disorder patients: differences between bipolar I and II subtypes.

Giuseppe Maina1, Umberto Albert, Laura Bellodi, Cristina Colombo, Carlo Faravelli, Palmiero Monteleone, Filippo Bogetto, Giovanni B Cassano, Mario Maj.   

Abstract

OBJECTIVE: The aim of the present study was to compare health-related quality of life (HRQoL) measures in euthymic patients with bipolar I and II disorder. We included as comparison samples a group of subjects with recurrent major depression (RMD) and a group of non-psychiatrically ill individuals.
METHOD: HRQoL was assessed using the Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) in 253 subjects recruited in 5 Italian centers: 90 patients with bipolar I disorder, 52 patients with bipolar II disorder, 61 subjects with RMD, and 50 healthy comparison individuals. All subjects were evaluated with the Structured Clinical Interview for DSM-IV; psychiatric patients had to be in a euthymic state for at least 2 months prior to the inclusion in the study, as confirmed by a Hamilton Rating Scale for Depression total score < 8 and a Young Mania Rating Scale total score < 6. Data were drawn from a study that was performed from May 2003 to December 2004.
RESULTS: When we compared the bipolar and RMD groups with the control group of non-psychiatrically ill individuals and controlled for differences in mean actual age, both bipolar subgroups and subjects with RMD had lower SF-36 mean scores on several subscales; differences in mean SF-36 scores were also detected between bipolar subtypes: bipolar II patients showed HRQoL that was poorer than that of bipolar I patients, even after controlling for age, age at onset, and length of illness, and equal to that of RMD subjects.
CONCLUSION: Our study provides evidence that bipolar type II is associated with poorer HRQoL compared to type I even during sustained periods of euthymia and excluding residual symptoms. Interventions targeting rehabilitation and/or functional enhancement may be helpful to improve HRQoL, especially among patients with bipolar II disorder.

Entities:  

Mesh:

Year:  2007        PMID: 17335318     DOI: 10.4088/jcp.v68n0205

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  19 in total

1.  Mood disorder symptoms and elevated cardiovascular disease risk in patients with bipolar disorder.

Authors:  Juliette M Slomka; John D Piette; Edward P Post; Sarah L Krein; Zongshan Lai; David E Goodrich; Amy M Kilbourne
Journal:  J Affect Disord       Date:  2012-02-21       Impact factor: 4.839

2.  Psychotherapy Alone and Combined With Medication as Treatments for Bipolar II Depression: A Randomized Controlled Trial.

Authors:  Holly A Swartz; Paola Rucci; Michael E Thase; Meredith Wallace; Elisa Carretta; Karen L Celedonia; Ellen Frank
Journal:  J Clin Psychiatry       Date:  2018 Mar/Apr       Impact factor: 4.384

Review 3.  Pharmacotherapy for the treatment of acute bipolar II depression: current evidence.

Authors:  Holly A Swartz; Michael E Thase
Journal:  J Clin Psychiatry       Date:  2010-08-10       Impact factor: 4.384

4.  Quality of life in Iranian patients with bipolar disorder: a psychometric study of the Persian Brief Quality of Life in Bipolar Disorder (QoL.BD).

Authors:  Amirhossein Modabbernia; Mohammadhossein Yaghoubidoust; Chung-Ying Lin; Bengt Fridlund; Erin E Michalak; Greg Murray; Amir H Pakpour
Journal:  Qual Life Res       Date:  2015-12-29       Impact factor: 4.147

5.  Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.

Authors:  Lakshmi N Yatham; Sidney H Kennedy; Sagar V Parikh; Ayal Schaffer; David J Bond; Benicio N Frey; Verinder Sharma; Benjamin I Goldstein; Soham Rej; Serge Beaulieu; Martin Alda; Glenda MacQueen; Roumen V Milev; Arun Ravindran; Claire O'Donovan; Diane McIntosh; Raymond W Lam; Gustavo Vazquez; Flavio Kapczinski; Roger S McIntyre; Jan Kozicky; Shigenobu Kanba; Beny Lafer; Trisha Suppes; Joseph R Calabrese; Eduard Vieta; Gin Malhi; Robert M Post; Michael Berk
Journal:  Bipolar Disord       Date:  2018-03-14       Impact factor: 6.744

Review 6.  New Developments in the Use of Atypical Antipsychotics in the Treatment of Bipolar Disorder: a Systematic Review of Recent Randomized Controlled Trials.

Authors:  Kamyar Keramatian; Trisha Chakrabarty; Gayatri Saraf; Lakshmi N Yatham
Journal:  Curr Psychiatry Rep       Date:  2021-05-08       Impact factor: 5.285

7.  Psychotherapy for Bipolar II Disorder: The Role of Interpersonal and Social Rhythm Therapy.

Authors:  Holly A Swartz; Jessica C Levenson; Ellen Frank
Journal:  Prof Psychol Res Pr       Date:  2012-04

8.  Clinical correlates of patients with rapid-cycling bipolar disorder and a recent history of substance use disorder: a subtype comparison from baseline data of 2 randomized, placebo-controlled trials.

Authors:  Keming Gao; Marcia L Verduin; David E Kemp; Bryan K Tolliver; Stephen J Ganocy; Omar Elhaj; Sarah Bilali; Kathleen T Brady; Robert L Findling; Joseph R Calabrese
Journal:  J Clin Psychiatry       Date:  2008-07       Impact factor: 4.384

9.  A qualitative investigation of hypomania and depression in bipolar II disorder.

Authors:  Kathryn Fletcher; Gordon Parker; Vijaya Manicavasagar
Journal:  Psychiatr Q       Date:  2013-12

10.  Psychotherapy as monotherapy for the treatment of bipolar II depression: a proof of concept study.

Authors:  Holly A Swartz; Ellen Frank; Debra R Frankel; Danielle Novick; Patricia Houck
Journal:  Bipolar Disord       Date:  2009-02       Impact factor: 6.744

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.